- call +1-201-465-4211
- email sales@mrinsights.biz
Alzheimer’s is a complex disease，though many marketed drugs have been approved for Alzheimer’s disease, but it still remains a significant area of unmet medical need. Currently there’s no cure for Alzheimer’s and its still waiting for its key product, numerous companies are developing novel treatments.
Scope of the Report:
This report focuses on the Alzheimer's Disease Patients in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
As the risk of getting the disease increases with age, the number of patients with the illness to be found in community will depend on the proportion of older people in the group.
Traditionally, the developed countries have large proportions of elderly people, and so they have many cases of Alzheimer’s disease in the community at one time.
At the mean time, developing countries are also undergoing a demographic transition so that more and more persons are surviving to an old age.
The worldwide market for Alzheimer's Disease Patients is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Forest Laboratorie
Eisai
H. Lundbeck A/S
Novartis
Merz GmbH & Co. KGaA
Johnson & Johnson
UCB
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Exelon
Aricept
Namenda
Razadyne
Axura
Ebixa
Nootropil
Prometax
Memac
Eranz
Market Segment by Applications, can be divided into
Hospital
Drug Store
There are 15 Chapters to deeply display the global Alzheimer's Disease Patients market.
Chapter 1, to describe Alzheimer's Disease Patients Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Alzheimer's Disease Patients, with sales, revenue, and price of Alzheimer's Disease Patients, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Alzheimer's Disease Patients, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Alzheimer's Disease Patients market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Alzheimer's Disease Patients sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Alzheimer's Disease Patients Introduction
1.2 Market Analysis by Type
1.2.1 Exelon
1.2.2 Aricept
1.2.3 Namenda
1.2.4 Razadyne
1.2.5 Axura
1.2.6 Ebixa
1.2.7 Nootropil
1.2.8 Prometax
1.2.9 Memac
1.2.10 Eranz
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Drug Store
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Forest Laboratorie
2.1.1 Business Overview
2.1.2 Alzheimer's Disease Patients Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Forest Laboratorie Alzheimer's Disease Patients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eisai
2.2.1 Business Overview
2.2.2 Alzheimer's Disease Patients Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eisai Alzheimer's Disease Patients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 H. Lundbeck A/S
2.3.1 Business Overview
2.3.2 Alzheimer's Disease Patients Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 H. Lundbeck A/S Alzheimer's Disease Patients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Alzheimer's Disease Patients Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Alzheimer's Disease Patients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Merz GmbH & Co. KGaA
2.5.1 Business Overview
2.5.2 Alzheimer's Disease Patients Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merz GmbH & Co. KGaA Alzheimer's Disease Patients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Johnson & Johnson
2.6.1 Business Overview
2.6.2 Alzheimer's Disease Patients Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Johnson & Johnson Alzheimer's Disease Patients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 UCB
2.7.1 Business Overview
2.7.2 Alzheimer's Disease Patients Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 UCB Alzheimer's Disease Patients Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Alzheimer's Disease Patients Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Alzheimer's Disease Patients Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Alzheimer's Disease Patients Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Alzheimer's Disease Patients Manufacturer Market Share in 2017
3.3.2 Top 6 Alzheimer's Disease Patients Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Alzheimer's Disease Patients Market Analysis by Regions
4.1 Global Alzheimer's Disease Patients Sales, Revenue and Market Share by Regions
4.1.1 Global Alzheimer's Disease Patients Sales and Market Share by Regions (2013-2018)
4.1.2 Global Alzheimer's Disease Patients Revenue and Market Share by Regions (2013-2018)
4.2 North America Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
4.3 Europe Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
4.5 South America Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
5 North America Alzheimer's Disease Patients by Countries
5.1 North America Alzheimer's Disease Patients Sales, Revenue and Market Share by Countries
5.1.1 North America Alzheimer's Disease Patients Sales and Market Share by Countries (2013-2018)
5.1.2 North America Alzheimer's Disease Patients Revenue and Market Share by Countries (2013-2018)
5.2 United States Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
5.3 Canada Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
5.4 Mexico Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
6 Europe Alzheimer's Disease Patients by Countries
6.1 Europe Alzheimer's Disease Patients Sales, Revenue and Market Share by Countries
6.1.1 Europe Alzheimer's Disease Patients Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Alzheimer's Disease Patients Revenue and Market Share by Countries (2013-2018)
6.2 Germany Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
6.3 UK Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
6.4 France Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
6.5 Russia Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
6.6 Italy Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
7 Asia-Pacific Alzheimer's Disease Patients by Countries
7.1 Asia-Pacific Alzheimer's Disease Patients Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Alzheimer's Disease Patients Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Alzheimer's Disease Patients Revenue and Market Share by Countries (2013-2018)
7.2 China Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
7.3 Japan Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
7.4 Korea Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
7.5 India Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
8 South America Alzheimer's Disease Patients by Countries
8.1 South America Alzheimer's Disease Patients Sales, Revenue and Market Share by Countries
8.1.1 South America Alzheimer's Disease Patients Sales and Market Share by Countries (2013-2018)
8.1.2 South America Alzheimer's Disease Patients Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
8.3 Argentina Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
8.4 Colombia Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
9 Middle East and Africa Alzheimer's Disease Patients by Countries
9.1 Middle East and Africa Alzheimer's Disease Patients Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Alzheimer's Disease Patients Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Alzheimer's Disease Patients Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
9.3 UAE Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
9.4 Egypt Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
9.5 Nigeria Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
9.6 South Africa Alzheimer's Disease Patients Sales and Growth Rate (2013-2018)
10 Global Alzheimer's Disease Patients Market Segment by Type
10.1 Global Alzheimer's Disease Patients Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Alzheimer's Disease Patients Sales and Market Share by Type (2013-2018)
10.1.2 Global Alzheimer's Disease Patients Revenue and Market Share by Type (2013-2018)
10.2 Exelon Sales Growth and Price
10.2.1 Global Exelon Sales Growth (2013-2018)
10.2.2 Global Exelon Price (2013-2018)
10.3 Aricept Sales Growth and Price
10.3.1 Global Aricept Sales Growth (2013-2018)
10.3.2 Global Aricept Price (2013-2018)
10.4 Namenda Sales Growth and Price
10.4.1 Global Namenda Sales Growth (2013-2018)
10.4.2 Global Namenda Price (2013-2018)
10.5 Razadyne Sales Growth and Price
10.5.1 Global Razadyne Sales Growth (2013-2018)
10.5.2 Global Razadyne Price (2013-2018)
10.6 Axura Sales Growth and Price
10.6.1 Global Axura Sales Growth (2013-2018)
10.6.2 Global Axura Price (2013-2018)
10.7 Ebixa Sales Growth and Price
10.7.1 Global Ebixa Sales Growth (2013-2018)
10.7.2 Global Ebixa Price (2013-2018)
10.8 Nootropil Sales Growth and Price
10.8.1 Global Nootropil Sales Growth (2013-2018)
10.8.2 Global Nootropil Price (2013-2018)
10.9 Prometax Sales Growth and Price
10.9.1 Global Prometax Sales Growth (2013-2018)
10.9.2 Global Prometax Price (2013-2018)
10.10 Memac Sales Growth and Price
10.10.1 Global Memac Sales Growth (2013-2018)
10.10.2 Global Memac Price (2013-2018)
10.11 Eranz Sales Growth and Price
10.11.1 Global Eranz Sales Growth (2013-2018)
10.11.2 Global Eranz Price (2013-2018)
11 Global Alzheimer's Disease Patients Market Segment by Application
11.1 Global Alzheimer's Disease Patients Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Drug Store Sales Growth (2013-2018)
12 Alzheimer's Disease Patients Market Forecast (2018-2023)
12.1 Global Alzheimer's Disease Patients Sales, Revenue and Growth Rate (2018-2023)
12.2 Alzheimer's Disease Patients Market Forecast by Regions (2018-2023)
12.2.1 North America Alzheimer's Disease Patients Market Forecast (2018-2023)
12.2.2 Europe Alzheimer's Disease Patients Market Forecast (2018-2023)
12.2.3 Asia-Pacific Alzheimer's Disease Patients Market Forecast (2018-2023)
12.2.4 South America Alzheimer's Disease Patients Market Forecast (2018-2023)
12.2.5 Middle East and Africa Alzheimer's Disease Patients Market Forecast (2018-2023)
12.3 Alzheimer's Disease Patients Market Forecast by Type (2018-2023)
12.3.1 Global Alzheimer's Disease Patients Sales Forecast by Type (2018-2023)
12.3.2 Global Alzheimer's Disease Patients Market Share Forecast by Type (2018-2023)
12.4 Alzheimer's Disease Patients Market Forecast by Application (2018-2023)
12.4.1 Global Alzheimer's Disease Patients Sales Forecast by Application (2018-2023)
12.4.2 Global Alzheimer's Disease Patients Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Alzheimer's Disease Patients Picture
Table Product Specifications of Alzheimer's Disease Patients
Figure Global Sales Market Share of Alzheimer's Disease Patients by
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
